Societal Perspectives in Economic Analyses and Real-World Cost-Effectiveness Studies in Cancer
Deadline for manuscript submissions: closed (15 March 2022) | Viewed by 25611
Interests: patients’ out-of-pocket costs; financial toxicity; patient and caregiver lost income; economic evaluation; health policy
Special Issues, Collections and Topics in MDPI journals
The economic evaluation of health technologies for cancer is frequently seen in the literature, but not all economic perspectives are seen with the same frequency. Although a health system perspective is commonly used to address the needs of the payer, these analyses tend to ignore the broader impact on patients. In order to understand these broader perspectives, economic evaluations need to include other effects, such as patient out-of-pocket costs, travel costs, lost income for patients and caregivers, and their combined impacts on quality of life.
Similarly, the majority of cost-effectiveness analyses in cancer are based on clinical trials, which typically lack generalizability. Additional analyses that examine cost-effectiveness in real-world settings by using government and private payer databases or modeling techniques allow readers to understand whether trial-based cost-effectiveness aligns with the results seen after technology approval.
In this Special Issue we encourage those with ongoing work in these areas to submit their manuscripts. The intent is to give priority to manuscripts that meet one or both of the above listed foci. We also encourage indigenous population analyses if available in your datasets
Dr. Christopher J. Longo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- real-world outcomes
- societal perspective
- economic evaluation
- out-of-pocket costs
- patient income loss